Resources

Type of publications
Regions
Diseases

5192 results found

2025 ∙ Rezahosseini, O. Bazargan, A. Eiberg, M. F. Korsgaard, A. P. Niyati, R. Ekenberg, C. Nielsen, L. N. Harboe, Z. B.

Safety and Immunogenicity of Co-Administration of Herpes Zoster Vaccines with Other Vaccines in Adults: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • Herpes zoster
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Larney, C. Foley, P. Daniel, B. S.

Safety and Immunogenicity of Live Attenuated Vaccine Administration in Patients Undergoing Treatment With Dupilumab and Apremilast: A Systematic Review

  • Adults
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Chen, D. Wu, Y. Liu, H. Yang, L. Wang, N. Wu, P.

Safety of chikungunya vaccines for adolescents and adults: A meta-analysis

  • Adolescents
  • Adults
  • Chikungunya
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Boccalini, S. Del Riccio, M. Crescioli, G. Salvati, C. Sadotti, A. Cacini, C. Cerini, G. Iamarino, J. A. Ionita, G. Stancanelli, E. Albora, G. Bonanni, P. Vannacci, A. Bechini, A.

Safety of co-administration of injectable vaccines in individuals under 18 years of age: A systematic literature review

  • Newborn
  • Children
  • Adolescents
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Bandell, A. Giles, L. Cervelo Bouzo, P. Sibbring, G. C. Maniaci, J. Wojtczak, H. Sokolow, A.

Safety of LAIV Vaccination in Asthma or Wheeze: A Systematic Review and GRADE Assessment

  • Children
  • Adolescents
  • Adults
  • Influenza
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Tiozzo, G. de Roo, A. M. Hofstra, H. S. Gurgel do Amaral, G. S. Vondeling, G. T. Postma, M. J. Freriks, R. D.

Safety of live attenuated vaccines in immunocompromised individuals and pregnant women: a systematic literature review

  • All age groups
  • Pregnant women
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Garcia Flores, A. B. Ruiz-Montero, R. Onieva-Garcia, M. A. Batista-Duharte, A. Lopez Cabrera, E. Farouk Allam, M. Salcedo, I.

Safety Profile of the 4CMenB (Bexsero<sup></sup>) Vaccine: A Systematic Review and Meta-Analysis of Adverse Events in Clinical Trials

  • All age groups
  • Meningococcal disease
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Thone, P. Egger, M. Gruber, M. S. Gruber, G. Kasassov, C. Nyiri, D. Weis, E. Werl, H. Trinkl, L. Lilleby, W. Clodi, M. Brautigam, E. Dieplinger, B. Aigner, A. Geinitz, H.

Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Radiation-Oncology Patients: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Chiavarini, M. Genga, A. Ricciotti, G. M. D'Errico, M. M. Barbadoro, P.

Safety, Immunogenicity, and Efficacy of Cytomegalovirus Vaccines: A Systematic Review of Randomized Controlled Trials

  • All age groups
  • Cytomegalovirus
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Al-omoush, O. Khalil, L. Ramadan, A. Tarakhan, H. Alzoubi, A. Nabil, A. Hajali, M. Abdelazeem, B. Saleh, O.

Sarcoidosis and COVID-19 Vaccines: A Systematic Review of Case Reports and Case Series

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...